Imaging Diagnostic Systems' hopes of joining the mammography sweepstakes are pinned on its computed tomography laser mammography (CTLM) system gaining FDA premarket approval next year.IDS in Plantation, FL, has been developing its system for several
Imaging Diagnostic Systems' hopes of joining the mammography sweepstakes are pinned on its computed tomography laser mammography (CTLM) system gaining FDA premarket approval next year.
IDS in Plantation, FL, has been developing its system for several years. It hopes to complete the PMA process early in 2001. Another company, Advanced Research and Technology (ART) of Montreal, is working on a similar system, called SoftScan.
Both SoftScan and IDS's CTLM system train the laser energy on one side of the breast and place a detector on the other side to catch the photons after they pass through the tissue.
The ART system uses a stationary light source to create 2-D images, whereas CTLM's lasers rotate around the breast to create 3-D tomographic images. ART likewise hopes to clear the FDA in 2001 and begin marketing its product in 2002.
Both systems are considered adjuncts to x-ray mammography. n
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.